Related and Nonrelated Parties [Axis]
Nonrelated Party [Member]
Related Party [Member]
Equity Components [Axis]
Common Stock [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Shelf Registration Statement [Member]
ATM Sales Agreement [Member]
Sales Agreement [Member]
Plan Name [Axis]
Equity Incentive Plan 2021 - 2025 [Member]
Award Type [Axis]
Share-Based Payment Arrangement, Option [Member]
Underswriters Common Share Warrants [Member]
Statistical Measurement [Axis]
Maximum [Member]
Underswriters Warrants [Member]
Sale of Stock [Axis]
IPO [Member]
ATM Offering Costs [Member]
Financial Instrument [Axis]
Available-for-Sale Securities [Member]
Fair Value Hierarchy and NAV [Axis]
Fair Value, Inputs, Level 1 [Member]
Fair Value, Inputs, Level 2 [Member]
Fair Value, Inputs, Level 3 [Member]
Mandatory Convertible Bond [Member]
Related Party Transaction [Axis]
Research And Development Expense Related Party [Member]
Investment Type [Axis]
Allowance For Corporate Equity [Member]
Italian Additional Corporate Tax [Member]
Title and Position [Axis]
Director [Member]
Vesting [Axis]
Share-Based Payment Arrangement, Tranche One [Member]
Share-Based Payment Arrangement, Tranche Two [Member]
Minimum [Member]
Servicing Assets and Servicing Liabilities Risk [Axis]
Interest Rate Risk [Member]
Measurement Input Type [Axis]
Measurement Input, Option Volatility [Member]
Scenario [Axis]
Investment round [Member]
Change of Control [Member]
Maturity [Member]
Dissolution [Member]
American Depository Shares [Member]
Officers and Employee [Member]
Statement of Income Location, Balance [Axis]
Research and Development Expense [Member]
General and Administrative Expense [Member]
Accumulated Net Unrealized Gain Loss [Member]
Accumulated Translation Adjustments [Member]
Third Parties [Member]
Product and Service [Axis]
Consultants and Other Third Parties [Member]
Related Parties [Member]
Materials and Supplies [Member]
Compensation [Member]
Travel and Entertainment [Member]
Other [Member]
Accounting Legal and Other Professional [Member]
Communication and IT Related [Member]
Facility and Insurance Related [Member]
Pierluigi Paracchi [Member]
Retirement Plan Name [Axis]
Trattamento Di Fine Rapporto [Member]
Naldini [Member]
Dr.Gentner [[Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Dr Carlo Russos LLC [Member]
Richard Slansky [Member]
Finance Employee One [Member]
Finance Employee Two [Member]
Finance Employee Three [Member]
First Indication [Member]
Second Indication [Member]
Third Indication [Member]
Amended and Restated OSR License Agreement [Member]
Sublicense Agreement [Member]
Amendment to OSR Amendedand Restated License Agreement [Member]
First Solid Cancer Indication Option Fee [Member]
Second Solid Cancer Indication Option Fee [Member]
Amended and Restated License Agreement [Member]
OSR Sponsor Research Agreement [Member]
Studio Legale Lexia [Member]
San Raffaele Hospital OSR [Member]
Carlo Russo [Member]
Bernhard Gentner [Member]
OSR Operating Leases and Office Rent [Member]
AGC Manufacturing [Member]
Insurance Policy [Member]
Original OSR License Agreement [Member]
San Raffaele Hospital [Member]
Legal Entity [Axis]
OSR [Member]
Master Service Agreement [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Income Statement [Abstract]
Operating expenses
Research and development
General and administrative
Total operating expenses
Loss from operations
Other income (expense)
Other income
Finance income
Net exchange rate gain (loss)
Total other income (expense), net
Loss before income taxes
Income tax benefit (expense)
Net loss
Net loss per share - basic
Weighted average number of shares outstanding - basic
Weighted average number of shares outstanding - diluted
Other comprehensive income/(loss)
Total change of marketable debt securities
Change in foreign currency translation
Total other comprehensive income/(loss)
Comprehensive loss
Defined Benefit Plan [Table]
Defined Benefit Plan Disclosure [Line Items]
Assets
Current assets
Cash and cash equivalents
Marketable securities
Prepaid expenses and other current assets
Total current assets
Non-current assets
Fixed assets, net
Other non-current assets
Total non-current assets
Total assets
Liabilities and shareholders’ equity
Current liabilities
Accounts payable
Accrued expenses
Other current liabilities
Total current liabilities
Non-current liabilities
Mandatory convertible bond - at fair value
Other non-current liabilities
Retirement benefit obligation
Total long-term liabilities
Commitments and contingencies
Shareholders’ equity
Ordinary shares, no par value, 59,700,000 shares authorized and 19,146,468 and 18,289,866 shares issued and outstanding, respectively
Accumulated deficit
Accumulated other comprehensive income
Total shareholders’ equity
Total liabilities and shareholders’ equity
Statement of Financial Position [Abstract]
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Statement [Table]
Statement [Line Items]
Balance
Balance, shares
Share-based compensation
Capital increase ATM program
Capital increase ATM program, shares
Other comprehensive income (loss)
Net loss
Balance
Balance, shares
Statement of Cash Flows [Abstract]
Cash flows from operating activities
Adjustments to reconcile net loss to net cash used in operating activities:
Foreign exchange adjustment
Depreciation expense
Retirement benefit obligation
Share-based compensation
Fair value loss on convertible bond
Fair value adjustments on available-for-sale financial instruments
Changes in operating assets and liabilities
Prepaid expenses and other current assets
Other non-current assets
Accounts payable
Accounts payable - related party
Accrued expenses
Accrued expenses - related party
Other current liabilities
Other non-current liabilities
Net cash used in operating activities
Cash flows from investing activities
Purchases of marketable securities
Proceeds from maturities of marketable securities
Purchases of fixed assets
Net cash (used in) provided by investing activities
Cash flows from financing activities
Proceeds from the ATM program
Proceeds from the convertible bond
Net cash provided by financing activities
Effect of exchange rate changes
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at the beginning of the period
Cash and cash equivalents at the end of the period
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of business and history
Accounting Policies [Abstract]
Summary of significant accounting policies
Research and Development [Abstract]
Research and development
General And Administrative
General and administrative
Income Tax Disclosure [Abstract]
Income taxes
Cash and Cash Equivalents [Abstract]
Cash and cash equivalents
Marketable securities
Fair Value Disclosures [Abstract]
Fair value measurements
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid expenses and other current assets
Property, Plant and Equipment [Abstract]
Fixed assets, net
Other non-current assets
Retirement Benefits [Abstract]
Retirement benefit obligation
Debt Disclosure [Abstract]
Mandatory convertible bond issuance
Equity [Abstract]
Shareholders’ equity
Share-Based Payment Arrangement [Abstract]
Share-based compensation
Accumulated Other Comprehensive Income
Related Party Transactions [Abstract]
Related parties
Commitments and Contingencies Disclosure [Abstract]
Commitments and contingencies
Subsequent Events [Abstract]
Subsequent events
Basis of presentation
Principles of consolidation
Use of estimates
Cash and cash equivalents
Marketable securities
Mandatory convertible bond
Net loss and comprehensive income (loss)
Net loss per share
Foreign currency translation
Emerging growth company status
Segment information
Tax credit on investments in research and development
Share-based compensation
Representative warrants
Non-current assets right-of-use
Fixed assets
Impairment of long-lived assets
Deferred offering costs
Recently issued accounting pronouncements
Schedule of cash and cash equivalents
Schedule of marketable securities
Schedule of fair value of assets classification
Schedule of fair value of liabilities classification
Schedule of prepaid expenses and other current assets
Schedule of fixed assets,net
Schedule of other non-current assets
Schedule of fair valuation monte carlo model
Schedule of corporate scenarios model
Schedule of outstanding stock options
Schedule of share based compensation expenses
Schedule of accumulated other comprehensive income
Schedule of third party and general and administrative expenses
Schedule of accounts payable to related parties
Schedule of accrued expenses to related parties
Schedule of company obligations by contractual maturity
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Proceeds from issuance or sale of equity
Sale of stock, value
Stock issued during period, value, new issues
Common stock, shares outstanding
Number of shares sold
Sale of stock value of share available to be sold
Sale of stock commission percentage
Net loss
Accumulated deficit
Cash and cash equivalents and marketable securities
Property, Plant and Equipment [Table]
Property, Plant and Equipment [Line Items]
Comprehensive loss
Common stock, capital shares reserved for future issuance
Stock issued during period, shares, new issues
Share-based compensation arrangement by share-based payment award, options, outstanding, number
Foreign exchange net loss
Number of operating segments
Effective income tax rate reconciliation, tax credit, research, amount
Share-based compensation arrangement by share-based payment award, expiration period
Share-based compensation arrangement by share-based payment award, number of shares authorized
Share-based compensation arrangement by share-based payment award, percentage
Share-based compensation arrangement by share-based payment award, options, number of shares, period increase (decrease)
Share-based compensation arrangement by share-based payment award, number of shares available for grant
Number of outstanding common shares
Class of warrant or right, exercise price of warrants or rights
Offering costs
Percentage of taxable income
Cash in bank
Cash in short-term marketable securities
Cash in hand & prepaid cards
Total cash and cash equivalents
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss
Debt Securities, Available-for-Sale, Excluding Accrued Interest
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain (Loss), before Tax
Debt Securities, Available-for-Sale, Allowance for Credit Loss
Unrealized gain loss
Fair Value, off-Balance-Sheet Risk [Table]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Cash and cash equivalents
Marketable Securities
Total cash and cash equivalents and marketable securities
Convertible Debt, Noncurrent
Value Added Tax (VAT)
Research and development tax credit
Advances payments to suppliers
Other current assets
Other prepaids
Total
Related Party Transaction [Table]
Related Party Transaction [Line Items]
VAT rate percentage
Short-term VAT receivable
Accrued VAT receivable
Value added tax refund received
Value added tax refund received short-term
Value added tax refund received long-term
Research and development tax credit
Taxes payable
Research and development expenses
Software (ERP Implementation)
Equipment
Total fixed assets
Less: accumulated depreciation
Fixed assets, net
Value Added Tax (VAT)
Research and development tax credit
Other non-current assets - related party
Total other non-current asssets
Value added tax
R&D tax credit
Lease term
Annual lease payment
Monthly lease payment
Discount rate
ROU asset and liability
ROU asset and current lease liability
Annual accrual
Annual accrual percentage
Obligation amount
Effective date
Event date
Nominal value
Risk-free rate
Instrument term
Stock volatility
GNTA share price
Instrument term
Number of simulations
Implied yield
Probability
Average bond balance
Average payoff balance
Discount rate
PV factor
PV
Schedule of Long-Term Debt Instruments [Table]
Debt Instrument [Line Items]
Payment for bonds
Maturity date
Conversion formula
Conversion price cap
Equity cap
Discount percentage
Interest percentage
Debt, weighted average interest rate
Debt instrument fair value interest rate
lock-up
Financial expenses
Debt instrument fair value
Accumulated Other Comprehensive Income (Loss) [Table]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Ordinary stock, shares issued
Ordinary stock, shares outstanding
Common shares reserved
Shares issued
Value of shares issued
Fair value of the stock options grant
Number of options outstanding, Beginning
Weighted average exercise price outstanding, Beginning
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Aggregate intrinsic value outstanding, Beginning
Number of options, Granted
Weighted average exercise price, Granted
Weighted average remaining contractual term (Years), Granted
Aggregate intrinsic value, Granted
Number of options, Vested and exercised
Weighted average exercise price, Vested and exercised
Aggregate intrinsic value, Vested and exercised
Number of options, Cancelled or forfeited
Weighted average exercise price, Cancelled or forfeited
Aggregate intrinsic value, Cancelled or forfeited
Number of options outstanding, Ending
Weighted average exercise price outstanding, Ending
Aggregate intrinsic value outstanding,Ending
Number of options,Exercisable
Weighted average exercise price, Exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Aggregate intrinsic value, Exercisable
Number of options outstanding, Expected to vest
Weighted average exercise price outstanding, Expected to vest
Weighted average remaining contractual term (years) Outstanding expected to vest
Aggregate intrinsic value outstanding, Expected to vest
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total
Unrecognized expense
Share based payment award options outstanding number
Stock options, granted remaining amount
Share-based compensation arrangement by share-based payment award, shares issued in period
Expected term
Shares purchased for award
Share-based compensation arrangement by share-based payment award, terms of award
Share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period
Stock options, granted
Exercise price per share
Share-based payment arrangement, expense
Share-based compensation expense
Exercise price
Options granted
Weighted average number of shares outstanding, basic
Weighted average number of shares outstanding, diluted
Ordinary shares, par value
Beginning Balance
Adjustment for net (gain) loss on marketable securities
Change in fair value of marketable securities
Cumulative translation adjustment
Total
Unrealized net gain on marketable securities
Total
Total
Total
Total
Other general and administrative costs
Depreciation expenses
Insurance cost limited liability
Membership fees
Patent maintenance
Other various minor expenses
Gross salary
Percentage of annual bonus
Issued invoices
Gross amount
Gross amount
Non qualified shares received
Shares received
Social contribution amount
Annual fee
Annual compensation
Agreement term description
One time fee payment
Billed paid
Annual gross salary
Compensation expense
Vested shares
Vested amount
Paid in cash
Bonus amount accrued
Accrued performance bonuses
Future option fees
Upfront fee
Taxes and licenses
Other Commitments, Description
Operating costs and expenses
Option fee
Cash consideration
Payments to acquire
Accrued expenses to related parties
Total
Less than a year
1 to 3 years
4 to 5 years
More than 5 years
Other commitments description
Principal amount
Costs and expenses, related party
Manufacturing costs
Percentage of royalties
Production costs
Rent payment
Finance income expenses.
Change of marketable debt securities.
Third Parties [Member]
Related Parties [Member]
Cash in short-term marketable securities.
Payment for bonds.
Mandatory Convertible Bond [Member]
Compensation [Member]
Accounting Legal and Other Professional [Member]
Communication and IT Related [Member]
Facility and Insurance Related [Member]
Consultants and Other Third Parties [Member]
Other [Member]
Increase decrease in accounts payable related party.
Increase decrease in accrued liabilities related party.
Accumulated Net Unrealized Gain Loss [Member]
Accumulated Translation Adjustments [Member]
Sharebased compensation arrangement by sharebased payment award options outstanding weighted average remaining contractual term granted.
Share based compensation arrangement by share based payment award options granted aggregate intrinsic value.
Share based compensation arrangement by share based payment award options cancelled or forfeited aggregate intrinsic value.
Schedule of Fair Value of Assets [Table Text Block].
Fair value loss on convertible bond.
Schedule of Fair Value of Liabilities [Table Text Block].
Fair value adjustments on available for sale financial instruments.
Officers and Employee [Member]
Decrease in other general and administrative costs.
Research and development tax credit.
Percentage of value added tax.
Share based compensation expense.
Decrease in limited liability insurance cost.
Proceeds from value added tax refunds received long term.
Proceeds from value added tax refunds received short term.
Proceeds from value added tax refunds received long term.
Increase in patent maintenance costs.
Other cumulative change.
American Depository Shares [Member]
Membership fees.
Research And Development Expense Related Party [Member]
Schedule of Accounts Payable to Related Parties [Table Text Block]
Schedule of Accrued Expense to Related Parties [Table Text Block]
Studio Legale Lexia [Member]
Bernhard Gentner [Member]
Pierluigi Paracchi [Member]
Percentage of annual bonus
ATM Sales Agreement [Member]
Sales Agreement [Member]
Allowance For Corporate Equity [Member]
Equity Incentive Plan 2021 - 2025 [Member]
Italian Additional Corporate Tax [Member]
Sale of stock value of share available to be sold.
Sale of stock commission percentage.
Mandatory Convertible Bond [Policy Text Block]
Net Loss and Comprehensive Loss [Policy Text Block]
Underswriters Common Share Warrants [Member]
Emerging Growth Company Status [Policy Text Block]
Tax Credit on Investments in Research and Development [Policy Text Block]
Research and development tax credit non current.
Other Noncurrent Assets.
Representative Warrants [Policy Text Block]
Underswriters Warrants [Member]
Noncurrent Assets Right of Use ROU [Policy Text Block]
Non qualified shares received.
ATM Offering Costs [Member]
General And Administrative Disclosure [Text Block]
Percentage of taxable income.
Trattamento Di Fine Rapporto [Member]
Annual fee.
Naldini [Member]
Dr.Gentner [[Member]
Finance lease monthly principal payments.
Defined contribution plan maximum annual contributions per employee description.
Agreed to payment of one time fee.
Financial expenses.
Debt instrument discount percentage.
Dr Carlo Russos LLC [Member]
Debt instrument fair value rate.
Richard Slansky [Member].
OSR [Member]
AGC Manufacturing [Member]
Insurance Policy [Member]
Payments by period, less than a year
OSR Operating Leases and Office Rent [Member]
Contractual obligation due in one to third year
Debt instrument effective date.
Original OSR License Agreement [Member]
Future option fees
First Indication [Member]
Second Indication [Member]
Third Indication [Member]
Upfront fee.
Amended and Restated OSR License Agreement [Member]
Sublicense Agreement [Member]
Amendment to OSR Amendedand Restated License Agreement [Member]
First Solid Cancer Indication Option Fee [Member]
San Raffaele Hospital [Member]
Option fee.
Second Solid Cancer Indication Option Fee [Member]
Total project cash consideration.
Number of simulations.
OSR Sponsor Research Agreement [Member]
Percentage of Royalties.
Master Service Agreement [Member]
Investment round [Member]
Change of Control [Member]
Dissolution [Member]
Maturity [Member]
Average bond balance amount.
Average payoff amount.
Share based compensation arrangement by share based payment award options vested and expected to vest outstanding value.
Bond present value factor price per share.
Finance Employee One [Member]
Finance Employee Two [Member]
Finance Employee Three [Member]
Bond present value factor amount.
Bond equity volatility percentage.
Shelf Registration Statement [Member]
Schedule of Corporate Scenarios Model [Table Text Block]
Materials and Supplies [Member]
Travel and Entertainment [Member]
San Raffaele Hospital OSR [Member]
Carlo Russo [Member]
Bond adjusted implied yield percentage.
Instrument term
Amended And Restated License Agreement [Member]
Total other non current assets.
Accrued value added tax receivable
Operating Expenses
Operating Income (Loss)
Nonoperating Income (Expense)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Assets, Current
Assets, Noncurrent
Assets [Default Label]
Liabilities, Current
Liabilities, Noncurrent
Equity, Attributable to Parent
Liabilities and Equity
Gain (Loss), Foreign Currency Transaction, before Tax
Pension and Other Postretirement Benefits Expense (Reversal of Expense), Noncash
Share-Based Payment Arrangement, Noncash Expense
FairValueAdjustmentsOnAvailableforsaleFinancialInstruments
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Other Noncurrent Assets
Increase (Decrease) in Accounts Payable
Increase (Decrease) in Accrued Liabilities
Increase (Decrease) in Other Current Liabilities
Increase (Decrease) in Other Noncurrent Liabilities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Payments to Acquire Marketable Securities
Payments to Acquire Property, Plant, and Equipment
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect, Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
Research, Development, and Computer Software Disclosure [Text Block]
GeneralAndAdministrativeDisclosureTextBlock
Cash and Cash Equivalents Disclosure [Text Block]
Cash, Cash Equivalent, and Marketable Security [Text Block]
Other Current Assets [Text Block]
Property, Plant and Equipment Disclosure [Text Block]
Other Assets Disclosure [Text Block]
Retirement Benefits [Text Block]
Equity [Text Block]
Share-Based Payment Arrangement [Text Block]
Commitments and Contingencies Disclosure [Text Block]
Cash and Cash Equivalents, Policy [Policy Text Block]
Marketable Securities, Policy [Policy Text Block]
Share-Based Payment Arrangement, Forfeiture [Policy Text Block]
Stock Issued During Period, Value, Other
Cash and Cash Equivalents, Fair Value Disclosure
Prepaid Expense, Current
Property, Plant and Equipment, Gross
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
TotalOtherNoncurrentAssets
InstrumentTerm
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
Accrued Bonuses
Contractual Obligation